Insight Molecular Diagnostics IMDX
NASDAQ IMDX
$3.47 -0.12 (-3.34%)
At close: Oct 1, 2026 · 4:00 PM EDT

Insight Molecular Diagnostics (IMDX) Non-Current Deferred Tax Liability (2020)

Updated

Insight Molecular Diagnostics (IMDX) posted Non-Current Deferred Tax Liability of $158,000 for Q3 2020, unchanged from the prior quarter.

Analysis

Insight Molecular Diagnostics (IMDX) Non-Current Deferred Tax Liability (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn
10 Insight Molecular Diagnostics 117.12 Mn 40.83 Mn 157,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 158,000.00
Jun 30, 2020 158,000.00
Mar 31, 2020 158,000.00
API Access

Insight Molecular Diagnostics Non-Current Deferred Tax Liability API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deferred-tax-liability&ticker=IMDX&period=max&api_key=YOUR_API_KEY